Marina Varga

Dr. Marina Varga

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
LSLiza Dalma Dalma Sümegi
Liza Dalma Dalma Sümegi
MVMarina Varga
Marina Varga
VKVeronika Kadocsa
Veronika Kadocsa
BSBalázs Szili
Balázs Szili
MSMárk Stempler
Márk Stempler
ITIstvan Takacs
Istvan Takacs
Background: Despite a large number of published studies, the effect of vitamin D3 supplementation on mortality in hospitalized patients, as well as the recommended dose and duration of therapy, is unclear. In our retrospective study, we aimed to investigate the impact of vitamin D deficiency and moderately high-dose vitamin D3 supplementation on mortality and disease outcomes in patients with COVID-19 infection. Methods: We analyzed data from 148 COVID-19-infected hospitalized patients in two different departments, Internal Medicine and Oncology, at Semmelweis University. The severity of COVID-19 and the treatment used were the same except at one of the departments, where patients received circa 90,000 IU of vitamin D3. We compared in-hospital mortality rates between the groups. In a subgroup analysis, we evaluated the efficacy and safety of vitamin D3 supplementation by assessing 25(OH)D and 1,25(OH)2D concentrations on days 0, 4, and 8. Results: As a result of the supplementation, the deficiency was resolved in 4 days in deficient patients, and none of the 25(OH)D or 1,25(OH)2D concentrations exceeded the normal range. Mortality was significantly lower and decreased 67% in the group receiving vitamin D3 supplementation, regardless of baseline 25(OH)D concentrations. Conclusions: The supplemental dosage, 3 × 30,000 IU of vitamin D3, is effective and safe and may reduce mortality in COVID-19 infection.

28 July 2017 in Analytical Methods
Verified
Journal Article
Open access
PDF file
ZSZsuzsanna Szeitner
Zsuzsanna Szeitner
ADAnna Doleschall
Anna Doleschall
MVMarina Varga
Marina Varga
KKKatalin Keltai
Katalin Keltai
KRKatalin Révész
Katalin Révész
TMTamás Mészáros
Tamás Mészáros
We demonstrate the first application of a nuclease resistant aptamer, the so-called Spiegelmer, in a sandwich-type affinity assay by quantitative assessment of cardiac Troponin I (cTnI) in blood serum samples.